Jeevan Scientific Technology Ltd — Important, 22-01-2026: Company Update

Jeevan Scientific Technology Limited (JSTL) confirms the United States Food and Drug Administration (US FDA) has concluded its remote regulatory assessment. This assessment involved a remote review of studies conducted at JSTL's clinical pharmacology facility in Hyderabad. The US FDA has now issued its Remote Regulatory Assessment Report, marking the completion of this important regulatory oversight process. This provides clarity regarding the company's operational status concerning US FDA compliance for stakeholders.